Q3 2023 Holdings
Filed 2023-11-14 | 30 holdings | $855.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $104.4M | 4,428,072 | 12.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $74.7M | 5,450,000 | 8.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $63.0M | 1,845,000 | 7.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $56.1M | 1,100,000 | 6.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $54.3M | 5,566,026 | 6.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $47.6M | 2,075,000 | 5.6% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $40.5M | 3,518,556 | 4.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $39.6M | 2,901,816 | 4.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $38.4M | 2,525,753 | 4.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $38.4M | 1,000,000 | 4.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $38.1M | 828,778 | 4.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $33.7M | 2,200,000 | 3.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $28.6M | 565,000 | 3.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $26.2M | 887,500 | 3.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $20.9M | 775,000 | 2.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $19.4M | 706,665 | 2.3% |
| Celcuity Inc(CELC) | COM | 15102K100 | $15.5M | 1,694,141 | 1.8% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $15.2M | 1,325,000 | 1.8% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $15.0M | 10,000,000 | 1.8% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $14.9M | 500,000 | 1.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $13.9M | 957,509 | 1.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $12.8M | 1,400,000 | 1.5% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $10.9M | 1,700,000 | 1.3% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $9.1M | 739,661 | 1.1% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $8.3M | 1,575,000 | 1.0% |
| Rayzebio Inc | COM | 75525N107 | $6.4M | 288,911 | 0.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $5.3M | 250,000 | 0.6% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.9M | 2,244,378 | 0.3% |
| Aeglea Biotherapeutics Inc(SYRE) | COM NEW | 00773J202 | $1.4M | 116,324 | 0.2% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $126.1K | 92,687 | 0.0% |